To access this material please log in or register

Register Authorize

Liver function in patients with chronic heart failure in interrelation with clinical and hemodynamic parameters

Abdullaev T. A., Saburov M. Yu., Mardanov B. U., Akhmatov Ya. R.

Keywords: haemodynamics, clinical picture, hepatic function, CHF

DOI: 10.18087/rhfj.2012.1.1511

Relevance. Hepatic lesion is a relatively common complication of CHF, which sets on as congestive hepatopathy conditioned by inferior vena cava hypertension. The development of this condition severely aggravates the course of main disease. Objective. Comparative study of liver lesions of various etiologies in CHF patients in interrelation with clinical and hemodynamic parameters. Materials and methods. 82 patients with CHF conditioned by ischemic and idiopathic dilated cardiomyopathies were enrolled to the study. All patients underwent examination of clinical state, CHF FC verification and assessment of exercise tolerance by means of 6‑minute walking test, as well as transthoracal echoCG and biochemical blood analysis. Results. In some third of patients with CHF of various etiologies and without primary liver lesion, clinical and laboratory signs of hepatic dysfunction were revealed, including the development of cirrhosis. Hyperbilirubinemia was noted to be the most common manifestation of hepatopathy. Hypoalbuminemia and hypolipidemia accompanied by more pronounced signs of the remodeling of both right and left heart were registered more often in CHF patients with signs of hepatic dysfunction. Conclusion. The obtained data do not answer many questions concerning the direction of the revealed interrelation (primary nature of the process), role of dysfunction of other organs (due to lack of perfusion) in the development of the described changes, which makes it necessary to continue studies in this area.
  1. Maggioni AP, Opasich C, Anand I et al. Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice. J Card Fail. 2005;11 (2):91–98.
  2. Jankowska EA, Biel B, Majda J et al. Prevalence of complex anabolic deficiency, and its relationships with clinical status and prognosis in men with chronic heart failure. Eur J Heart Fail. 2005;4 (Suppl 1):62.
  3. Naschitz JE, Yeshurun D, Shahar J. Cardiogenic hepatorenal syndrome. Angiology. 1990;41 (11):893–900.
  4. Allen LA, Felker GM, Pocock S et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009;11 (2):170–177
  5. Комаров Ф. И., Коровкин Б. Ф., Меньшиков В. В. Биохимические исследования в клинике. – Элиста: АПП «Джангар», 2001. – 216 с.
  6. Lainscak M, Hodoscek-Majc L, Majc D et al. Liver Function Markers and Mortality in Patients with Chronic Heart Failure. Circulation. 2008;118:S_616.
  7. Gelow JM, Desai AS, Hochberg CP et al. Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail. 2010;3 (1):59–64.
  8. Kubo SH, Walter BA, John DH et al. Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med. 1987;147 (7):1227–1230.
  9. Roberto F, Opasich C, Tavazzi L. Heart failure: 181 questions and answers. France, 2003, 448 р.
  10. Сторожаков Г. И., Эттингер О. А. Поражение печени при хронической сердечной недостаточности. Журнал Сердечная Недостаточность. 2005;6 (1):28–32.
  11. Horwich TB, Hamilton MA, Maclellan WR, Fonarow GC. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail. 2002;8 (4):216–224.
  12. Сметанина И. Н., Деев А. Д., Грацианский Н. А. Уровни общего холе­стерина и глюкозы крови – факторы независимо связанные с риском смерти и госпитализации у больных с ХСН. Кардиология. 2007;47 (8):12–16.
  13. David D. Koch: Handbook of Interpretation of Diagnostic Tests. Jacques Wallach. Philadelphia, PA: Lippincott-Raven Publishers, 1998. – 564 pp.
  14. Stenson RE, Constantino RT, Harrison DC. Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man. Circulation. 1971;43 (2):205–211.
  15. Krag A, Bendtsen F, Henriksen JH, Møller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut. 2010;59 (1):105–110.
  16. Lau GT, Tan HC, Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol. 2002;90 (12):1405–1409.
Abdullaev T. A., Saburov M. Yu., Mardanov B. U. et al. Liver function in patients with chronic heart failure in interrelation with clinical and hemodynamic parameters. Russian Heart Failure Journal. 2012;13(1):9-12

To access this material please log in or register

Register Authorize
Ru En